Position in TRVI
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$5,323,069
+$1,884,728 QoQ
Shares Held
446,192
+62.5% QoQ
Ownership
0.314%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 99.89376770538244.ToString("F0")%
Shared 0.ToString("F0")%
None 0.10623229461756376.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,969,172 across 554 Biotechnology names. TRVI ranks #145 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in TRVI
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,323,069 | 446,192 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,438,341 | 274,628 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,732,298 | 298,612 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,937,610 | 354,225 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $585,177 | 93,033 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $187,521 | 45,515 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $93,059 | 27,862 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $53,666 | 18,009 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $145,307 | 42,118 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $42,045 | 31,377 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $49,213 | 22,575 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $57,491 | 24,055 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $14,023 | 7,580 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,965 | 3,091 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $6,586 | 4,277 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $13,406 | 4,771 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $3,572 | 1,624 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $7,242 | 5,173 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,808 | 2,137 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,444 | 2,378 | Shares | Sole | 2021-05-12 | |
| 2020-03-31 | $1,779 | 541 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||